Product Revenue, Net was Jaguar Health’s largest revenue line in fiscal 2025, bringing in $11.34M of $11.51M (99%).
| Products and Services | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue, Net | $11.96M | $9.76M | $11.56M | $11.34M | ||||||
| Product Revenue | — | — | — | — | ||||||
| Collaboration Revenue | — | — | — | — | ||||||
| License | — | — | $129.00K | $172.00K | ||||||
| Neonorm | — | — | — | — | ||||||
| Botanical Extract | — | — | — | — | ||||||
| Total | $11.96M | $9.76M | $11.69M | $11.51M |
Jaguar Health brought in $11.51M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was down 1.5% from $11.69M in fiscal 2024. Product Revenue, Net was the largest at $11.34M (98.5%), ahead of License at $172.00K (1.5%).
Jaguar Health began breaking out License in fiscal 2024, when it brought in $129.00K.
Human Health was Jaguar Health’s largest segment in fiscal 2025, bringing in $11.16M of $11.51M (97%).
| Segment | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Human Health | $11.74M | $9.59M | $11.37M | $11.16M | ||||||
| Animal Health | $215.00K | $173.00K | $315.00K | $353.00K | ||||||
| Total | $11.96M | $9.76M | $11.69M | $11.51M |
Jaguar Health brought in $11.51M from its two segments in fiscal 2025, the year ended December 31, 2025. That was down 1.5% from $11.69M in fiscal 2024. Human Health was the largest at $11.16M (96.9%), ahead of Animal Health at $353.00K (3.1%).
Compared with fiscal 2024, Animal Health grew 12.1% to $353.00K, while Human Health fell 1.9% to $11.16M. From fiscal 2022 to 2025, combined revenue from these segments fell from $11.96M to $11.51M, a compound annual decline of 1.3%. Human Health's share of the total fell from 98.2% to 96.9%.
Jaguar Health (JAGX) reports its revenue by products and services and by segment. In fiscal 2025, Product Revenue, Net was its largest revenue line, bringing in $11.34M (98.5% of the total), followed by License at $172.00K (1.5%).
Product Revenue, Net was Jaguar Health's largest revenue line in fiscal 2025, bringing in $11.34M, or 98.5% of the $11.51M total across its two revenue lines.
Human Health was Jaguar Health's largest segment in fiscal 2025, bringing in $11.16M, or 96.9% of the $11.51M total across its two segments.
Animal Health grew faster than Human Health in fiscal 2025, up 12.1% from $315.00K to $353.00K. Human Health fell 1.9% to $11.16M.
Every figure comes from Jaguar Health's annual financial filings, as reported. Each line keeps the name Jaguar Health gives it, and years follow its fiscal calendar.
Jaguar Health's revenue by products and services goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.